Inside Lyme Podcast with Dr. Daniel Cameron
Health & Fitness:Medicine
Babesia microti in a Multiple Sclerosis patient
I will be discussing findings from a 54-year-old male with a 12-year history of multiple sclerosis who was diagnosed with Babesia microti.
This article was written by Haberli and colleagues in the journal Multiple Sclerosis and Related Disorders.
He failed treatment with 4 different disease modifying drugs ─ glatiramer acetate, natalizumab, dimethyl fumarate, and fingolimod. He was lost to followup for 6 years.
He was seen again 12 years after the onset of his multiple sclerosis. The doctor suspected a recurrence of his multiple sclerosis and treated him with another disease modifying drug called Ocrevus™.
He was hospitalized 4 months later for possible sepsis. He was diagnosed with Babesia. He required 8 weeks of treatment.
There are two unanswered question. Was the flareup of multiple sclerosis after 12 years due to Babesia. Or was the severity of his Babesia due to taking an immunosuppressive agent Ocrevus™.
1. Haberli N, Coban H, Padam C, Montezuma-Rusca JM, Creed MA, Imitola J. Babesia microti infection in a patient with multiple sclerosis treated with ocrelizumab. Mult Scler Relat Disord.
You can hear more about these cases through his blogs, social media, and YouTube. Sign up for our newsletter to keep up with these cases.
How to Connect with Dr. Daniel Cameron:
We, of course, hope you’ll join the conversation, connect with us and other readers, ask questions, and share your insights.
Dr. Cameron is a Lyme disease expert and the author "Inside Lyme: An expert's guide to the science of Lyme disease." He has been treating adolescents and adults for more than 30 years.
Please remember that the advice given is general and not intended as specific advice as to any particular patient. If you require specific advice, then please seek that advice from an experienced professional.
Create your
podcast in
minutes
It is Free